Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT001 in Progressive Supranuclear Palsy
NCT04937530Phase 2Unknown
- Sponsor
- BioJiva LLC
- Start
- Jun 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RT001 in progressive supranuclear palsy (PSP), sponsored by BioJiva LLC. Status: unknown.
02
Drugs
RT001
03
Conditions
progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on NCT04937530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04937530.